High prevalence of HBV and HCV infection among intravenous drug users in Korea

Journal of Medical Virology

Volumn 80, Issue 9, 2008, Pages 1570-1575

  Yun, Haesun ^a   Kim, Daijin ^b   Kim, Soyeon ^a   Kang, Sujin ^a   Jeong, Seunghee ^a   Cheon, Yonghoon ^c   Joe, Keunho ^d   Gwon, Do Hoon ^e   Cho, Sung Nam ^e   Jee, Youngmee ^a  

^a Korea National Institute of Health   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Kilian Keaney Emotion Behavior Research Institute   (South Korea)

^d Eulji University   (South Korea)

^e Bugok National Hospital   (South Korea)

Author keywords

Genotype; Hepatitis B virus (HBV); Hepatitis C virus (HCV); Intravenous drug user

Indexed keywords

METHAMPHETAMINE; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; GENOTYPE; HEALTH PROGRAM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; KOREA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; SCHOOL CHILD; SEROPREVALENCE; STUDENT T TEST; VIRUS DETECTION; VIRUS STRAIN; VIRUS TRANSMISSION;

ADULT; COMORBIDITY; DNA, VIRAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; HUMANS; KOREA; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 48249100419     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21255     Document Type: Article

References (28)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press.
2. Baveja UK, Chattopadhya D, Khera R, Joshi PM. 2003. A cross sectional serological study of the co-infection of hepatitis b virus, hepatitis c virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian J Med Microbiol 21:280-283.
3. Bowden S, McCaw R, White PA, Crofts N, Aitken CK. 2005. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. J Viral Hepat 12:322-324.
4. Chu CM, Sheen IS, Liaw YF. 2004. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection. Scand J Gastroenterol 39:778-782.
5. Elghouzzi MH, Bouchardeau F, Pillonel J, Boiret E, Tirtaine C, Barlet V, Moncharmont P, Maisonneuve P, du Puy-Montbrun MC, Lyon-Caen D, Courouce AM. 2000. Hepatitis C virus: Routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors. Vox Sang 79:138-144.
6. Harder J, Walter E, Riecken B, Ihling C, Bauer TM. 2004. Hepatitis C virus infection in intravenous drug users. Clin Microbiol Infect 10:768-770.
7. KCDC. 2006. The Third Korea National Health and Nutrition Examination Survey (KNHANES), 2005. Korea Centers for Disease Control and Prevention. Rep 71.
8. Kim BG, Park HK, Rim HD, Cho SN, Kim JY, Kwon SM, Kwon DH. 2005. Demographic and clinical characteristics of hospitalized patients with methamphetamine dependence. J Korean Acad Addict Psychiatry 9:56-61.
9. Kim HS, Choo DH. 1996. Prevalence of hepatitis C, B, and human immunodeficiency virus among drug users and chronic alcoholic patients in Korea. Korean J Intern Med 11:38-43.
10. Kim SS, Park DK, Park JJ, Kim YK, Kang DH, Choi DJ, Park HC, Hwang YJ, Kim JH. 2000. Distribution of hepatitis C virus genotypes among intravenous drug users. Korean J Gastroenterol 35:458-465.
11. Kim SW, Yoon YM. 1997. Seroprevalence study of hepatitis C and hepatitis B virus infection in drug abusers. Korean J Invest Dermatol 4:89-94.
12. Kim YS, Ahn YO, Lee HS. 2002. Risk factors for hepatitis C virus infection among Koreans according to the hepatitis C virus genotype. J Korean Med Sci 17:187-192.
13. Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. 2003. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol 69:367-375.
14. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. 2002. Epeidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 17:457-462.
15. Lee GC, Kim HG, Park NH, Won SY, Chung YH, Lee YS, Suh DJ. 1998. Distribution of hepatitis C virus genotypes determined by line probe assay in Korean patients with chronic HCV infection. Korean J Hepatol 4:244-253.
16. Morice Y, Francois J, Pawlotsky JM. 2004. The HCV genotype 3a worldwide epidemics in intravenous drug users. Hepatology 40:177A.
17. Muga R, Sanvisens A, Bolao F, Toi J, Santesmases J, Puiol R, Tural C, Langohr K, Reyjoly C, Munoz A. 2006. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend 82:S29-S33.
18. Norden L, Lidman C. 2005. Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs). Scand J Infect Dis 37:493-496.
19. Shapatava E, Nelson KE, Tsertsvadze T, del Rio C. 2006. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among infection drug users in Georgia. Drug Alcohol Depend 82:S35-S38.
20. Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli C, Bruno S, Bellobuono A, Mondelli M. 1995. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 22:691-695.
21. Simmonds P. 1995. Variability of hepatitis C virus. Hepatology 21:570-583.
22. The Supreme Public Prosecutor's Office. The White paper of crime on narcotics in Korea. 2006. Publisher Sungmin. Seoul.
23. Torbenson M, Kannangai R, Astemborski J, Strathdee SA, Vlahov D, Thomas DL. 2004. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39:51-57.
24. Unskula A, Heimer R, Dehovitz J, Fischer K, McNutt LA. 2006. Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance. J Infect Dis 193:455-457.
25. Yoon SJ, Pae CU, Lee HJ, Choi BM, Kim TS, Lyoo IK, Kwon DH, Kim DJ. 2005. Ghrelin precursor gene polymorphism and methamphetamine dependence in the Korean population. Neurosci Res 53:391-395.
26. Wang YM, Ng WC, Lo SK. 1999. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore. J Gastroenterol 34:481-485.
27. WHO. guidelines for certification of achievement of hepatitis B control goal in the western Pacific Region. 2007.
28. Zein NN. 2000. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235.